Project Grant HT94252310870
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$766K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is providing $1,014,000.00 to the Icahn School of Medicine at Mount Sinai to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The research, which is scheduled to take place from September 1, 2024 to August 31, 2028, will leverage the institution's expertise in areas such as cancer biology, immunology, and clinical...
The Icahn School of Medicine at Mount Sinai will receive $1,521,002 under a three-year Project Grant award from the Defense Health Agency. The grant will support research from August 1, 2023 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). Specifically, the funding will enable research to determine the contribution of lineage intermediate tumor cells during progression to T-SCNC. This work aligns with the Military Medical Research and Development...
The Icahn School of Medicine at Mount Sinai has been awarded a $591,486 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, running from September 1, 2023 to August 31, 2026, will support the development of a novel immuno-oncology pipeline for FGFR2 fusion-positive cholangiocarcinoma. The funding will enable the medical school to conduct research aimed at transforming health care for service members and the...
The Icahn School of Medicine at Mount Sinai will receive $760,500 from the Defense Health Agency under a three-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to functionally identify high-dimensional driver combinations in basal-like breast cancer. Through February 1, 2023 to January 31, 2026, this award will support the Icahn School of Medicine's efforts to transform health care for service members and the...
The federal Project Grant award of $202,800.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by the Icahn School of Medicine at Mount Sinai to investigate "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis." The award has a performance period from September 30, 2025 to September 29, 2026. As a prominent academic medical center, the Icahn School of...
The Defense Health Agency awarded a $2,475,390.00 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2024 to August 31, 2028, will fund a multifaceted intervention titled "MULTIFACETED INTERVENTION TO RESTORE RESILIENCE AND OVERCOME RISK (MIRROR)." As a renowned academic medical center, ISMMS will leverage its expertise in areas such as...
The federal Project Grant award of $2,028,000.00 was provided by the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program, to the Icahn School of Medicine at Mount Sinai. The award, effective April 1, 2025, supports research to identify "epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer." The Icahn School of Medicine at Mount Sinai, a prominent academic medical center and research...
The Icahn School of Medicine at Mount Sinai (ISMMS) was awarded a $676,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "EPIGENETIC STUDIES OF CANDIDATE CELLS OF ORIGIN FOR DIFFUSE MIDLINE GLIOMA," is for a research project spanning from September 1, 2024, to August 31, 2026. The funding will support ISMMS's investigation into epigenetic factors that contribute to the development of diffuse...
The Icahn School of Medicine at Mount Sinai received a $591,694 Project Grant award from the Department of the Army Medical Command on September 15, 2021 to complete work by September 14, 2024. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions for battlefield medicine. Under this award, the Icahn School of Medicine at...
The Department of the Army Medical Command awarded a $3,300,817 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Icahn School of Medicine at Mount Sinai. The grant, with a performance period from June 1, 2025 to May 31, 2029, will support the institution's research to leverage personalized stem cell therapy to overcome airway reconstruction challenges. As a prominent academic medical center, the Icahn School of Medicine at Mount Sinai has extensive...